Ribavirin in ventilated respiratory syncytial virus bronchiolitis: A randomized, placebo-controlled trial

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 3, 1999, Pages 829-834

  Guerguerian, Anne Marie ^a   Gauthier, Marie ^a   Lebel, Marc H ^a   Farrell, Catherine Ann ^a   Lacroix, Jacques ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RIBAVIRIN;

ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA VIRUS INFECTION; TREATMENT OUTCOME;

EID: 0032828474     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.3.9810013     Document Type: Article

References (34)

1. Frankel, L. R., N. J. Lewiston, D. W. Smith, and D. K. Stevenson, 1986. Clinical observations on mechanical ventilation for respiratory failure in bronchiolitis. Pediatr. Pulmonol. 2:307-311.
2. Meert, K. L., A. P. Sarnaik, M. J. Gelmeni, and M. W. Lieh-Lai. 1994. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit. Care Med. 22:566-572.
3. Barry, W., F. Cockburn, R. Cornall, J. F. Price, G. Sutherland, and A. Vardag. 1986. Ribavirin aerosol for acute bronchiolitis. Arch. Dis. Child. 61:593-597.
4. Hall, C. B., J. T. McBride, F. E. Walsh, D. M. Bell, C. L. Gala, S, Hildreth, L. G. Ten Eyck, and W. J, Hall. 1983, Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection. N. Engl. J. Med. 308:1443-1447.
5. Smith, D. W., L. R. Frankel, L. H. Mathers, A. T. S. Tan, R. L. Ariagno, and C. G. Prober. 1991. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N. Engl. J. Med. 35:24-29.
6. Taber, L. H., V. Knight, and B. E. Gilbert. 1983. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants, Pediatrics 72:613-618.
7. American Academy of Pediatrics, and Committee on Infectious Disease. 1993. Use of ribavirin in the treatment of respiratory syncytial virus. Pediatrics 92:501-504.
8. American Academy of Pediatrics, and Committee on Infectious Disease, 1996. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 97:137-140.
9. Hall, C. B., R. G. Douglas, J. M. Geiman, and M. K. Messner. 1975. Nosocomial respiratory syncytial virus infections. N. Engl. J. Med. 293: 1343-1346.
10. Frankel, L. R., C. W. Wilson, R. R. Demers, J. R. Parker, N. J. Lewiston, D. K. Stevenson, and D. W. Smith. 1987. A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection, Crit. Care Med. 15:1051-1054.
11. Outwater, K. M., H. C. Meissner, and M. B. Peterson, 1988. Ribavirin administration to infants receiving mechanical ventilation. Am. J. Dis. Child. 142:512-515.
12. Ito, S., and G. Koren. 1993. Exposure of pregnant women to ribavirin-contaminated air: risk assessment and recommendations, Pediatr. Infect. Dis. J. 12:2-5.
13. Harrison, M. A., J. M. Lynch, J. M. Dean, and M. K. Witte. 1997, Comparison of simultaneous obtained arterial and capillary gases in pediatric intensive care unit patients. Crit. Care Med. 25:1904-1908.
14. Lachin, J. M. 1981. Introduction to sample size determination and power analysis for clinical trials. Control. Clin Trials 2:93-113.
15. Lebel, M. H., M. Gauthier, J. Lacroix, É. Rousseau, and M. Buithieu. 1989. Respiratory failure and mechanical ventilation in severe bronchiolitis. Arch. Dis. Child. 64:1431-1437.
16. Everard, M. L. 1996. Acute bronchiolitis - a perennial problem. Lancet 348:279-280.
17. Wang, E. L., B. J. Law, and D. Stephens. 1995. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J. Pediatr. 126:212-219.
18. Moler, F. W., C. M. Steinhart, S. E. Ohmit, and G. L. Stidham. 1996. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. J. Pediatr. 128:422-428.
19. Moler, F. W., K. P. Bandy, and J. R. Custer. 1991. Ribavirin therapy for acute bronchiolitis: need for appropriate controls. J. Pediatr. 119:509.
20. Wheeler, J. G., J. Wofford, and R. B. Turner, 1993. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection, Pidiatr. Infect. Dis. J. 12:209-213.
21. Law, B. J., E. E. L. Wang, N. N. Mac-Donald, J. McDonald, S. Dobson. F. Boucher, J. Langly, J. Robinson, I. Mitchell, and D. Stephens. 1997. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the Pediatric Investigators Collaborative Network on infections in Canada (PIC-NIC) RSV Database. Pediatrics 99:c7.
22. Navas, L., E. Wang, V. de Carvalho, J. Robinson, and the Pediatric Investigators Collaborative Network on Infections in Canada. 1992. Improved outcome of respiratory syncytial infection in a high-risk hospitalized population of Canadian children. J. Pediatr. 121:348-354.
23. Pon, S., and D. A. Notterman. 1995. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease. Crit. Care Med. 23:787.
24. Englund, J. A., P. A. Piedra, Y. M. Ahn, B. E. Gilbert, and P. Hiatt. 1994. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J. Pediatr. 125:635-641.
25. Micks, R. A., L. C. Olson, M. A. Jackson, and V. F. Burry. 1986. Precipitation of ribavirin causing obstruction of a ventilation tube, Pediatr. Infect. Dis. 5:707-708.
26. Quaid, M., S. Havalad, and S. Naidu. 1995. Airway resistance in infants on ribavirin (abstract). Crit. Care Med, 23:A185.
27. Sullivan, B. J. 1986. Respiratory syncytial virus and ribavirin. Pediatr. Infect. Dis. 3:605-606.
28. Canadian Paediatric Society. 1997. Use of ribavirin in the treatment of infections caused by respiratory syncytial virus. Pandiatr. Child Health 2:345-348.
29. Hall, C. B., K. R. Powel, N. E. MacDonald, C L. Gala, M. E. Mengus, S. C. Suffin, and H. J. Cohen. 1986. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 315:77-81.
30. Meert, K., S. Heidemann, B. Ahella, and A. P. Sarnaik. 1990. Docs prematurity alter the course of respiratory syncytial virus infection? Crit. Care Med. 18:1357-1359.
31. Kimpen, J. L. L., and U. B. Schaad. 1997. Treatment of respiratory syneytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases. Pediatr. Infect. Dis. J. 16:479-481.
32. Zucker, A. R., and W. L. Meadow. 1995. Pediatric critical care physicians' attitudes about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumonia, Crit. Care Med. 23:767-772.
33. Rodriguez, W. J., W. C. Gruber, R. C. Welliver, J, R. Groothuis, E. A. F. Simoes, C. Meissner, V. G. Hemming, C. B. Hall, M, L. Lepow, A. J. Rosas, C. Robertsen, A. A. Kramer, and for the Respiratory Syncytial Virus Immune Globulin Study Group. 1997, Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections. Pediatrics 99:454-461.
34. The Impact-RSV Study Group. 1998. Palivizumab, a humanized respiratory virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus in high-risk infants. Pediatrics 102:531-537.